209 related articles for article (PubMed ID: 34102919)
21. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of the APOE genotype on brain function across the lifespan.
Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE
Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142
[TBL] [Abstract][Full Text] [Related]
23. Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults.
Jefferson AL; Cambronero FE; Liu D; Moore EE; Neal JE; Terry JG; Nair S; Pechman KR; Rane S; Davis LT; Gifford KA; Hohman TJ; Bell SP; Wang TJ; Beckman JA; Carr JJ
Circulation; 2018 Oct; 138(18):1951-1962. PubMed ID: 30018169
[TBL] [Abstract][Full Text] [Related]
24. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
26. Increased hippocampal blood flow in sedentary older adults at genetic risk for Alzheimer's disease.
Zlatar ZZ; Wierenga CE; Bangen KJ; Liu TT; Jak AJ
J Alzheimers Dis; 2014; 41(3):809-17. PubMed ID: 24685629
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
28. Interaction of age and APOE genotype on cerebral blood flow at rest.
Wierenga CE; Clark LR; Dev SI; Shin DD; Jurick SM; Rissman RA; Liu TT; Bondi MW
J Alzheimers Dis; 2013; 34(4):921-35. PubMed ID: 23302659
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.
Bangen KJ; Restom K; Liu TT; Wierenga CE; Jak AJ; Salmon DP; Bondi MW
J Alzheimers Dis; 2012; 31 Suppl 3(0):S59-74. PubMed ID: 22531427
[TBL] [Abstract][Full Text] [Related]
30. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
[TBL] [Abstract][Full Text] [Related]
31. Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia study.
Dounavi ME; Low A; McKiernan EF; Mak E; Muniz-Terrera G; Ritchie K; Ritchie CW; Su L; O'Brien JT
J Cereb Blood Flow Metab; 2021 Nov; 41(11):2844-2855. PubMed ID: 34078163
[TBL] [Abstract][Full Text] [Related]
32. Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults.
Grau-Rivera O; Operto G; Falcón C; Sánchez-Benavides G; Cacciaglia R; Brugulat-Serrat A; Gramunt N; Salvadó G; Suárez-Calvet M; Minguillon C; Iranzo Á; Gispert JD; Molinuevo JL;
Alzheimers Res Ther; 2020 Jan; 12(1):4. PubMed ID: 31907066
[TBL] [Abstract][Full Text] [Related]
33. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
[TBL] [Abstract][Full Text] [Related]
34. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
[TBL] [Abstract][Full Text] [Related]
35. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE
Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534
[TBL] [Abstract][Full Text] [Related]
36. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
37. Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.
Goñi J; Cervantes S; Arrondo G; Lamet I; Pastor P; Pastor MA
J Alzheimers Dis; 2013; 33(4):1009-19. PubMed ID: 23064258
[TBL] [Abstract][Full Text] [Related]
38. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
39. APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.
Liu Y; Yu JT; Wang HF; Han PR; Tan CC; Wang C; Meng XF; Risacher SL; Saykin AJ; Tan L
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):127-34. PubMed ID: 24838911
[TBL] [Abstract][Full Text] [Related]
40. Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers.
Edlund AK; Chen K; Lee W; Protas H; Su Y; Reiman E; Caselli R; Nielsen HM
J Alzheimers Dis; 2021; 81(1):339-354. PubMed ID: 33814450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
